Korea Investors Service upgrades Samsung Biologics' credit rating to 'AA', citing enhanced business competitiveness, expanded production capacity, and favorable order conditions
#YonhapInfomax #SamsungBiologics #CreditRatingUpgrade #KoreaInvestorsService #BiopharmaceuticalIndustry #ProductionCapacity #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62492